(Press-News.org) A combination of inexpensive oral medications may be able to treat fatigue-inducing anemias caused by chronic diseases and inflammation, a new discovery from the University of Virginia School of Medicine suggests.
This type of anemia is the second-most common kind, and it can be an added burden for organ-transplant recipients and people with autoimmune disorders, as well as patients battling cancer or kidney disease and others. In addition to causing severe fatigue, the anemia can trigger headaches, dizziness, rapid heartbeat and sweating.
"Not only do these anemias cause unpleasant symptoms, but they are also associated with functional impairment and shorter lifespan," said researcher Adam Goldfarb, MD, the chief of UVA Health's Division of Experimental Pathology. "Drawbacks of current therapies include their expense, tendency to lose of effectiveness and risk for serious side effects. This new therapeutic approach has potential to provide a low-cost, highly effective, safe alternative. A further benefit would be its easy applicability to resource-limited areas around the world."
Understanding Anemia
People with anemia have fewer red blood cells and less hemogloblin than normal. Red blood cells carry oxygen throughout the body, while hemoglobin is an iron-rich protein in the red blood cells that transports oxygen molecules.
There are several types of anemias, but anemia of chronic disease and inflammation is triggered by restricted iron delivery to the bone marrow cells that make red blood cells.
Goldfarb and his colleagues initially found that this inadequate availability of iron disrupts an important organelle inside our cells called the Golgi apparatus. This multi-layered organelle, which is shaped a bit like a ribbon candy, is responsible for packaging proteins and lipids (fats) vital to cells' healthy operations.
The researchers identified the underlying source of this problem as a breakdown of tiny microtubules, which provide critical scaffolding for Golgi assembly and for the intracellular transport machinery. Importantly, the researchers were able to pinpoint the trigger for this microtubule breakdown as the loss of a protein, ferritin, within the cell.
By knowing the root-cause of these cellular defects the scientists could tailor a targeted approach to reverse the problem in mouse models of anemia. Giving the lab mice a combination of two substances, isocitrate and fumarate, allowed ferritin recovery and microtubule regrowth, enabling long-term correction of anemia caused by inflammation.
This suggests that an inexpensive oral medication might one day help human patients, too. Pilot studies in patients with anemia associated with kidney disease are in the advanced planning phase.
"The need for new anemia therapies is highlighted by the abundance of new agents currently in early clinical trials," said Goldfarb, of UVA's Department of Pathology. "In defining a novel basic cellular response, our work has opened the door to a safe and simple therapy with unique potential for globally accessibility."
INFORMATION:
Findings Published
The researchers have published their findings in the scientific journal Nature Communications. The research team consisted of Goldfarb, Katie C. Freeman, Ranjit K. Sahu, Kamaleldin E. Elagib, Maja Holy, Abhinav Arneja, Renata Polanowska-Grabowska, Alejandro A. Gru, Zollie White III, Shadi Khalil, Michael J. Kerins, Aikseng Ooi, Norbert Leitinger, Chance John Luckey and Lorrie L. Delehanty.
The work was supported by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), grants R01 DK079924 and R01 DK101550; the National Heart, Lung and Blood Institute, grant R01 HL149667; National Cancer Institute, grant P30 CA44579; UVA's Medical Scientist Training Program, grant 5T32GM007267-38; and an NIDDK Research Supplement to Promote Diversity in Health-Related Research, 3R01DK079924-09A1S1.
To keep up with the latest medical research news from UVA, subscribe to the Making of Medicine blog.
The COVID-19 pandemic has highlighted health disparities for people of color, who have been disproportionately affected by the pandemic. People with opioid use disorder (OUD) faced unique challenges when many mental health and addiction services were forced to scale back operations or temporarily close when social distancing guidelines were put in place.
A group of researchers in the College of Agriculture, Health and Natural Resources recently published their findings in the Journal of Substance Abuse and Treatment about the experiences of racial-ethnic minorities during the COVID-19 pandemic among people with OUD.
Doctoral ...
The Middle East and North Africa Region (MENA) is a climate change hot spot where summers warm much faster than in the rest of the world. Some parts of the region are already among the hottest locations globally. A new international study predicts that ignoring the signals of climate change and continuing business-as-usual will lead to extreme and life-threatening heatwaves in the region. Such extraordinary heat events will have a severe impact on the people of the area.
The study, which aims at assessing emerging heatwave characteristics, was led by scientists from the Climate and Atmosphere Research Center (CARE-C) of The Cyprus Institute and the Max Planck Institute for Chemistry, with the contribution of researchers from the CMCC Foundation - Euro-Mediterranean ...
People with certain blood types are more likely to have blood clots or bleeding conditions, kidney stones, or pregnancy-induced hypertension, suggests a study published today in eLife.
The study confirms previously identified connections between certain blood types and the risk of blood clots and bleeding, and makes a new connection between kidney stones and having type B blood as compared to O. The discoveries may lead to new insights on how a person's blood type may predispose them to developing a certain disease.
Previous studies have found that people with blood type A or B were more likely to have cardiovascular disease or experience ...
TROY, N.Y. -- When combined with drugs currently used to treat hepatitis C, the antiviral remdesivir is 10 times more effective in treating cells infected with SARS-CoV-2, the virus that causes COVID-19.
Published this week in Cell Reports, this finding -- from Gaetano Montelione, a professor of chemistry and chemical biology at Rensselaer Polytechnic Institute, and his collaborators at the Icahn School of Medicine at Mount Sinai and the University of Texas at Austin -- raises the potential for repurposing available drugs as COVID-19 antivirals in cases where a vaccine isn't practical or effective.
Remdesivir, which blocks viral replication by interfering with a viral polymerase, must ...
ADELPHI, Md. -- Army researchers developed a technique that allows robots to remain resilient when faced with intermittent communication losses on the battlefield.
The technique, called α-shape, provides an efficient method for resolving goal conflicts between multiple robots that may want to visit the same area during missions including unmanned search and rescue, robotic reconnaissance, perimeter surveillance and robotic detection of physical phenomena, such as radiation and underwater concentration of lifeforms.
Researchers from the U.S. Army Combat Capabilities Development Command, known as DEVCOM, Army Research Laboratory and the University of Nebraska, Omaha ...
In a uniquely deep and detailed look at how the commonly used anesthetic propofol causes unconsciousness, a collaboration of labs at The Picower Institute for Learning and Memory at MIT shows that as the drug takes hold in the brain, a wide swath of regions become coordinated by very slow rhythms that maintain a commensurately languid pace of neural activity. Electrically stimulating a deeper region, the thalamus, restores synchrony of the brain's normal higher frequency rhythms and activity levels, waking the brain back up and restoring arousal.
"There's a folk psychology or tacit assumption that what anesthesia does is simply 'turn off' the brain," said ...
Ecologists at the University of Cologne's Institute of Zoology have for the first time demonstrated the enormously high and also very specific species diversity of the deep sea in a comparison of 20 deep-sea basins in the Atlantic and Pacific Oceans. Over a period of 20 years, a research team led by Professor Dr Hartmut Arndt at the Institute of Zoology has compiled a body of data that for the first time allows for a comparison of the diversity of existing eukaryotes - organisms with a cell nucleus. Sediment samples from depths of 4000 to 8350 meters, ...
Tokyo, Japan - Human T-cell lymphotropic virus type-1 (HTLV-1) is a retrovirus similar to human immunodeficiency virus (HIV) and has mostly been thought to be transmitted vertically (mother-to-child), or horizontally (sexually or parenterally (e.g. via blood transfusion)). The spread of this infection in metropolitan areas such as Tokyo is presumed to be due to horizontal transmission, especially sexual transmission.HTLV-1-associated diseases are thought to be caused mainly through vertical transmission. In a new study, clinicians from Tokyo Medical and Dental University (TMDU) describe that horizontal transmission route ...
Most conventional molecular diagnostics usually detect only a single disease-related biomarker. Great examples are the PCR tests currently used to diagnose COVID-19 by detecting a specific sequence from SARS-CoV-2. Such so-called singleplex methods provide reliable results because they are "calibrated" to a single biomarker. However, determining whether a patient is infected with a new SARS-CoV-2 variant or a completely different pathogen requires probing for many different biomarkers at one time.
Scientists from the Helmholtz Institute for RNA-based ...
PHILADELPHIA (April 27, 2021) - Nurses and other clinicians rely heavily upon the electronic health record (EHR) to provide patient care. This includes clinical decision-making, care planning, patient surveillance, medication ordering and administration, and communication with other health care team members. While data show that EHR technology usability can put added burden on clinicians, the relationships between EHR usability and the job outcomes of hospital staff nurses and surgical patient outcomes have not been explored.
A new study from the University of ...
